Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + carboplatin versus 5-fluorouracil + carboplatin induction chemotherapy with concurrent carboplatin chemoradiotherapy for locally regionally advanced nasopharyngeal carcinoma
ChiCTR-TRC-12002626Phase 2Completed
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Oct 2005
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of docetaxel, carboplatin and fluorouracil in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Sun Yat-sen University Cancer Center. Primary endpoints: failure-free survival rate, overall survival rate and 4 more. Started Oct 2005; status: completed.
02
Drugs
docetaxelcarboplatinfluorouracil
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR-TRC-12002626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002626.